Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Neurodegenerative Disease

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1777762

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1777762

Alzheimer's Disease Diagnostics

PUBLISHED:
PAGES: 373 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Alzheimer's Disease Diagnostics Market to Reach US$17.5 Billion by 2030

The global market for Alzheimer's Disease Diagnostics estimated at US$9.2 Billion in the year 2024, is expected to reach US$17.5 Billion by 2030, growing at a CAGR of 11.4% over the analysis period 2024-2030. Imaging Techniques, one of the segments analyzed in the report, is expected to record a 12.5% CAGR and reach US$9.5 Billion by the end of the analysis period. Growth in the Biomarkers segment is estimated at 10.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.5 Billion While China is Forecast to Grow at 15.6% CAGR

The Alzheimer's Disease Diagnostics market in the U.S. is estimated at US$2.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.7 Billion by the year 2030 trailing a CAGR of 15.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.1% and 10.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.0% CAGR.

Global Alzheimer's Disease Diagnostics Market - Key Trends & Drivers Summarized

Why Is Early Diagnosis of Alzheimer’s Disease Gaining Critical Importance?

The early diagnosis of Alzheimer’s disease has become increasingly crucial as the global burden of neurodegenerative disorders continues to rise, with millions of individuals affected worldwide. The growing emphasis on early intervention is driven by the potential to slow disease progression, improve patient outcomes, and reduce healthcare costs associated with long-term care. Advances in diagnostic techniques are enabling healthcare professionals to identify Alzheimer's disease at its earliest stages, even before significant cognitive decline occurs. Biomarker-based tests, neuroimaging techniques, and genetic screening methods have emerged as essential tools in detecting early signs of the disease, providing clinicians with valuable insights into the underlying pathology. The increasing awareness among healthcare providers and patients about the benefits of early diagnosis is also contributing to the growing demand for reliable and accurate diagnostic solutions.

The integration of artificial intelligence (AI) and machine learning (ML) in diagnostic procedures is further revolutionizing the field, offering enhanced accuracy and efficiency in analyzing complex neurological data. AI-powered imaging analysis and predictive modeling are facilitating the early detection of subtle changes in brain structure and function, allowing for more personalized treatment approaches. Additionally, the rising adoption of non-invasive diagnostic methods, such as blood-based biomarkers and cerebrospinal fluid (CSF) tests, is making Alzheimer’s disease diagnosis more accessible and less burdensome for patients. As public health initiatives and advocacy groups continue to emphasize the importance of early detection, the market for Alzheimer's disease diagnostics is expected to witness significant growth.

What Role Do Technological Advancements Play in Enhancing Diagnostic Accuracy?

Technological advancements are playing a transformative role in enhancing the accuracy, speed, and accessibility of Alzheimer's disease diagnostics. The development of advanced imaging techniques, such as positron emission tomography (PET) and magnetic resonance imaging (MRI), has significantly improved the ability to visualize amyloid plaques and neurofibrillary tangles, which are key hallmarks of the disease. Innovations in radiotracer technologies have further enhanced the specificity of PET scans, enabling precise detection of beta-amyloid and tau protein accumulations in the brain. Additionally, the advent of fluid biomarker testing, including plasma-based assays and proteomics, has provided a less invasive and cost-effective alternative to traditional diagnostic methods, facilitating early and accurate diagnosis.

Next-generation sequencing (NGS) and other genomic profiling techniques have also revolutionized the landscape of Alzheimer's disease diagnostics by identifying genetic risk factors associated with disease progression. Advances in multiplex biomarker platforms have allowed for simultaneous detection of multiple biomarkers, improving diagnostic sensitivity and specificity. Moreover, digital health technologies, such as wearable devices and remote monitoring tools, are enabling continuous tracking of cognitive and behavioral changes, providing valuable data for early intervention and disease management. As the demand for more reliable and efficient diagnostic solutions grows, ongoing research and development efforts are expected to yield even more sophisticated tools for Alzheimer's disease detection and monitoring.

How Are Evolving Patient Preferences and Healthcare Trends Impacting the Market?

Evolving patient preferences and healthcare trends are reshaping the Alzheimer's disease diagnostics market, with an increasing focus on personalized and patient-centric approaches. Patients and caregivers are becoming more proactive in seeking early diagnostic options, driven by growing awareness of the disease and its impact on quality of life. The rising preference for non-invasive and home-based diagnostic solutions has led to the development of point-of-care testing kits and digital cognitive assessment tools that provide quick and convenient results. Furthermore, the integration of telemedicine services has enabled patients in remote and underserved areas to access diagnostic services, expanding market reach and improving early detection rates.

Healthcare providers are also adopting a more holistic approach to Alzheimer's diagnosis, incorporating cognitive testing, behavioral assessments, and lifestyle risk evaluations alongside traditional biomarker tests. The emphasis on multi-modal diagnostic strategies is helping to provide a comprehensive understanding of the disease, allowing for tailored treatment plans and personalized care strategies. In addition, the growing collaboration between diagnostic companies, pharmaceutical firms, and research institutions is fostering innovation and accelerating the development of novel diagnostic solutions. As the healthcare ecosystem continues to evolve, the Alzheimer's disease diagnostics market is poised to benefit from increased patient engagement and the growing demand for accessible and accurate testing options.

What Are the Key Factors Driving the Growth of the Alzheimer’s Disease Diagnostics Market?

The growth in the Alzheimer's disease diagnostics market is driven by several factors, including advancements in diagnostic technologies, increasing awareness about the importance of early detection, and the rising prevalence of the disease due to an aging population. The rapid development of biomarker-based tests and imaging techniques is improving diagnostic accuracy, while the adoption of AI-powered solutions is enhancing efficiency and reducing diagnostic turnaround times. The expanding application of fluid biomarkers and genetic testing is also contributing to market growth, offering clinicians more precise tools for disease risk assessment and monitoring. Furthermore, the growing demand for non-invasive and cost-effective diagnostic solutions is driving innovation in at-home testing kits and digital health platforms, catering to evolving consumer preferences. Government initiatives and funding for Alzheimer’s research, coupled with strategic collaborations among healthcare stakeholders, are further propelling market expansion. As the focus on early intervention and personalized medicine continues to grow, the Alzheimer’s disease diagnostics market is expected to witness sustained development and widespread adoption across various healthcare settings.

SCOPE OF STUDY:

The report analyzes the Alzheimer's Disease Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Diagnostics Technique (Imaging Techniques, Biomarkers, Cognitive Assessment Tests, Genetic Testing); Product Type (Diagnosis Products, Triage Products, Screening Products); End-Use (Hospitals End-Use, Diagnostic Laboratories End-Use, Academic and Research Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 37 Featured) -

  • Alector, Inc.
  • Bristol-Myers Squibb Company
  • C2N Diagnostics LLC
  • Cognition Therapeutics
  • F. Hoffmann-La Roche AG
  • Fujirebio Inc.
  • Laboratory Corporation of America Holdings
  • Quanterix Corporation
  • Quest Diagnostics, Inc.
  • Siemens Healthineers
  • Sysmex Corporation
  • Treventis Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP29116

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Alzheimer's Disease Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Breakthroughs in Biomarker Research Enhance Early Detection and Diagnostic Accuracy in Alzheimers Disease
    • Growing Adoption of Non-Invasive Blood-Based Diagnostic Tests Expands Market Accessibility and Screening Rates
    • Integration of Artificial Intelligence and Machine Learning in Alzheimers Diagnostics Improves Predictive Accuracy
    • Advancements in Neuroimaging Technologies Strengthen Early-Stage Detection and Disease Progression Monitoring
    • Wearable Devices and Digital Health Innovations Enable Continuous Cognitive Monitoring for Alzheimers Diagnosis
    • Rising Investment in Personalized Medicine and Precision Diagnostics Fuels Demand for Advanced Testing Solutions
    • Government and Private Sector Funding Initiatives Boost Research and Development in Alzheimers Disease Diagnostics
    • Regulatory Approvals and Fast-Track Designations for Novel Diagnostic Methods Accelerate Market Growth
    • Strategic Partnerships Between Pharmaceutical Companies and Diagnostic Firms Drive Innovation and Market Expansion
    • Rapidly Aging Global Population Increases Demand for Early and Reliable Alzheimers Disease Screening Solutions
    • Development of Multi-Modal Diagnostic Approaches Improves Sensitivity and Specificity in Alzheimers Testing
    • Rising Adoption of Point-of-Care and At-Home Testing Solutions Enhances Accessibility and Timely Diagnosis
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Alzheimer's Disease Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Alzheimer's Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Alzheimer's Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Imaging Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Imaging Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Imaging Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cognitive Assessment Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Cognitive Assessment Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Cognitive Assessment Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Genetic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Academic and Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Academic and Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Academic and Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Diagnostic Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Diagnosis Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Diagnosis Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Diagnosis Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Triage Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Triage Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Triage Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Screening Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Screening Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Screening Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Alzheimer's Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • JAPAN
    • Alzheimer's Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • CHINA
    • Alzheimer's Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • EUROPE
    • Alzheimer's Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Alzheimer's Disease Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Alzheimer's Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • FRANCE
    • Alzheimer's Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • GERMANY
    • Alzheimer's Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Alzheimer's Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Alzheimer's Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Alzheimer's Disease Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Alzheimer's Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Alzheimer's Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • INDIA
    • Alzheimer's Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Alzheimer's Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Alzheimer's Disease Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Alzheimer's Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Alzheimer's Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Alzheimer's Disease Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Alzheimer's Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030
  • AFRICA
    • Alzheimer's Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Alzheimer's Disease Diagnostics by Diagnostics Technique - Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Alzheimer's Disease Diagnostics by Diagnostics Technique - Percentage Breakdown of Value Sales for Imaging Techniques, Biomarkers, Cognitive Assessment Tests and Genetic Testing for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Alzheimer's Disease Diagnostics by End-Use - Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Alzheimer's Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Academic and Research Institutes End-Use, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Alzheimer's Disease Diagnostics by Product Type - Diagnosis Products, Triage Products and Screening Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Alzheimer's Disease Diagnostics by Product Type - Percentage Breakdown of Value Sales for Diagnosis Products, Triage Products and Screening Products for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!